ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antidiabetic Thiazolidinediones Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-24J6898
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Antidiabetic Thiazolidinediones Market Insights and Forecast to 2028
BUY CHAPTERS

Global Antidiabetic Thiazolidinediones Market Research Report 2025

Code: QYRE-Auto-24J6898
Report
August 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Takeda Pharmaceuticals
Eli Lilly
Merck
Novo Nordisk
Bristol–Myers Squibb
Pfizer Inc
Astrazeneca plc
GlaxoSmithKline PLC
Boehringer Ingelheim

Antidiabetic Thiazolidinediones Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antidiabetic Thiazolidinediones Market

Antidiabetic Thiazolidinediones Market

The global market for Antidiabetic Thiazolidinediones was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antidiabetic Thiazolidinediones, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidiabetic Thiazolidinediones.
The Antidiabetic Thiazolidinediones market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antidiabetic Thiazolidinediones market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antidiabetic Thiazolidinediones manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antidiabetic Thiazolidinediones Market Report

Report Metric Details
Report Name Antidiabetic Thiazolidinediones Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Takeda Pharmaceuticals, Eli Lilly, Merck & Co., Novo Nordisk, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antidiabetic Thiazolidinediones manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antidiabetic Thiazolidinediones in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Antidiabetic Thiazolidinediones Market report?

Ans: The main players in the Antidiabetic Thiazolidinediones Market are Sanofi, Takeda Pharmaceuticals, Eli Lilly, Merck & Co., Novo Nordisk, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim

What are the Application segmentation covered in the Antidiabetic Thiazolidinediones Market report?

Ans: The Applications covered in the Antidiabetic Thiazolidinediones Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Antidiabetic Thiazolidinediones Market report?

Ans: The Types covered in the Antidiabetic Thiazolidinediones Market report are Rosiglitazone, Pioglitazone

Recommended Reports

Diabetes & Heart Drugs

General Pharmaceuticals

Other Therapeutics

1 Antidiabetic Thiazolidinediones Market Overview
1.1 Product Definition
1.2 Antidiabetic Thiazolidinediones by Type
1.2.1 Global Antidiabetic Thiazolidinediones Market Value Comparison by Type (2024 VS 2031)
1.2.2 Rosiglitazone
1.2.3 Pioglitazone
1.3 Antidiabetic Thiazolidinediones by Application
1.3.1 Global Antidiabetic Thiazolidinediones Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Antidiabetic Thiazolidinediones Market Size Estimates and Forecasts
1.4.1 Global Antidiabetic Thiazolidinediones Revenue 2020-2031
1.4.2 Global Antidiabetic Thiazolidinediones Sales 2020-2031
1.4.3 Global Antidiabetic Thiazolidinediones Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antidiabetic Thiazolidinediones Market Competition by Manufacturers
2.1 Global Antidiabetic Thiazolidinediones Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antidiabetic Thiazolidinediones Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antidiabetic Thiazolidinediones Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antidiabetic Thiazolidinediones, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antidiabetic Thiazolidinediones, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antidiabetic Thiazolidinediones, Product Type & Application
2.7 Global Key Manufacturers of Antidiabetic Thiazolidinediones, Date of Enter into This Industry
2.8 Global Antidiabetic Thiazolidinediones Market Competitive Situation and Trends
2.8.1 Global Antidiabetic Thiazolidinediones Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antidiabetic Thiazolidinediones Players Market Share by Revenue
2.8.3 Global Antidiabetic Thiazolidinediones Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antidiabetic Thiazolidinediones Market Scenario by Region
3.1 Global Antidiabetic Thiazolidinediones Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antidiabetic Thiazolidinediones Sales by Region: 2020-2031
3.2.1 Global Antidiabetic Thiazolidinediones Sales by Region: 2020-2025
3.2.2 Global Antidiabetic Thiazolidinediones Sales by Region: 2026-2031
3.3 Global Antidiabetic Thiazolidinediones Revenue by Region: 2020-2031
3.3.1 Global Antidiabetic Thiazolidinediones Revenue by Region: 2020-2025
3.3.2 Global Antidiabetic Thiazolidinediones Revenue by Region: 2026-2031
3.4 North America Antidiabetic Thiazolidinediones Market Facts & Figures by Country
3.4.1 North America Antidiabetic Thiazolidinediones Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antidiabetic Thiazolidinediones Sales by Country (2020-2031)
3.4.3 North America Antidiabetic Thiazolidinediones Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antidiabetic Thiazolidinediones Market Facts & Figures by Country
3.5.1 Europe Antidiabetic Thiazolidinediones Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antidiabetic Thiazolidinediones Sales by Country (2020-2031)
3.5.3 Europe Antidiabetic Thiazolidinediones Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antidiabetic Thiazolidinediones Market Facts & Figures by Region
3.6.1 Asia Pacific Antidiabetic Thiazolidinediones Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antidiabetic Thiazolidinediones Sales by Region (2020-2031)
3.6.3 Asia Pacific Antidiabetic Thiazolidinediones Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antidiabetic Thiazolidinediones Market Facts & Figures by Country
3.7.1 Latin America Antidiabetic Thiazolidinediones Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antidiabetic Thiazolidinediones Sales by Country (2020-2031)
3.7.3 Latin America Antidiabetic Thiazolidinediones Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antidiabetic Thiazolidinediones Market Facts & Figures by Country
3.8.1 Middle East and Africa Antidiabetic Thiazolidinediones Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antidiabetic Thiazolidinediones Sales by Type (2020-2031)
4.1.1 Global Antidiabetic Thiazolidinediones Sales by Type (2020-2025)
4.1.2 Global Antidiabetic Thiazolidinediones Sales by Type (2026-2031)
4.1.3 Global Antidiabetic Thiazolidinediones Sales Market Share by Type (2020-2031)
4.2 Global Antidiabetic Thiazolidinediones Revenue by Type (2020-2031)
4.2.1 Global Antidiabetic Thiazolidinediones Revenue by Type (2020-2025)
4.2.2 Global Antidiabetic Thiazolidinediones Revenue by Type (2026-2031)
4.2.3 Global Antidiabetic Thiazolidinediones Revenue Market Share by Type (2020-2031)
4.3 Global Antidiabetic Thiazolidinediones Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antidiabetic Thiazolidinediones Sales by Application (2020-2031)
5.1.1 Global Antidiabetic Thiazolidinediones Sales by Application (2020-2025)
5.1.2 Global Antidiabetic Thiazolidinediones Sales by Application (2026-2031)
5.1.3 Global Antidiabetic Thiazolidinediones Sales Market Share by Application (2020-2031)
5.2 Global Antidiabetic Thiazolidinediones Revenue by Application (2020-2031)
5.2.1 Global Antidiabetic Thiazolidinediones Revenue by Application (2020-2025)
5.2.2 Global Antidiabetic Thiazolidinediones Revenue by Application (2026-2031)
5.2.3 Global Antidiabetic Thiazolidinediones Revenue Market Share by Application (2020-2031)
5.3 Global Antidiabetic Thiazolidinediones Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Antidiabetic Thiazolidinediones Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Takeda Pharmaceuticals
6.2.1 Takeda Pharmaceuticals Company Information
6.2.2 Takeda Pharmaceuticals Description and Business Overview
6.2.3 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product Portfolio
6.2.5 Takeda Pharmaceuticals Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Antidiabetic Thiazolidinediones Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Merck & Co.
6.4.1 Merck & Co. Company Information
6.4.2 Merck & Co. Description and Business Overview
6.4.3 Merck & Co. Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck & Co. Antidiabetic Thiazolidinediones Product Portfolio
6.4.5 Merck & Co. Recent Developments/Updates
6.5 Novo Nordisk
6.5.1 Novo Nordisk Company Information
6.5.2 Novo Nordisk Description and Business Overview
6.5.3 Novo Nordisk Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novo Nordisk Antidiabetic Thiazolidinediones Product Portfolio
6.5.5 Novo Nordisk Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Company Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Antidiabetic Thiazolidinediones Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Company Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AstraZeneca Antidiabetic Thiazolidinediones Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Company Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GlaxoSmithKline Antidiabetic Thiazolidinediones Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Company Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Boehringer Ingelheim Antidiabetic Thiazolidinediones Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antidiabetic Thiazolidinediones Industry Chain Analysis
7.2 Antidiabetic Thiazolidinediones Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antidiabetic Thiazolidinediones Production Mode & Process Analysis
7.4 Antidiabetic Thiazolidinediones Sales and Marketing
7.4.1 Antidiabetic Thiazolidinediones Sales Channels
7.4.2 Antidiabetic Thiazolidinediones Distributors
7.5 Antidiabetic Thiazolidinediones Customer Analysis
8 Antidiabetic Thiazolidinediones Market Dynamics
8.1 Antidiabetic Thiazolidinediones Industry Trends
8.2 Antidiabetic Thiazolidinediones Market Drivers
8.3 Antidiabetic Thiazolidinediones Market Challenges
8.4 Antidiabetic Thiazolidinediones Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Takeda Pharmaceuticals
Eli Lilly
Merck
Novo Nordisk
Bristol–Myers Squibb
Pfizer Inc
Astrazeneca plc
GlaxoSmithKline PLC
Boehringer Ingelheim
List of Tables
 Table 1. Global Antidiabetic Thiazolidinediones Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antidiabetic Thiazolidinediones Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antidiabetic Thiazolidinediones Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antidiabetic Thiazolidinediones Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Antidiabetic Thiazolidinediones Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antidiabetic Thiazolidinediones Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antidiabetic Thiazolidinediones Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antidiabetic Thiazolidinediones Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antidiabetic Thiazolidinediones, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antidiabetic Thiazolidinediones, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antidiabetic Thiazolidinediones, Product Type & Application
 Table 12. Global Key Manufacturers of Antidiabetic Thiazolidinediones, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antidiabetic Thiazolidinediones by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidiabetic Thiazolidinediones as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antidiabetic Thiazolidinediones Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antidiabetic Thiazolidinediones Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Antidiabetic Thiazolidinediones Sales Market Share by Region (2020-2025)
 Table 19. Global Antidiabetic Thiazolidinediones Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Antidiabetic Thiazolidinediones Sales Market Share by Region (2026-2031)
 Table 21. Global Antidiabetic Thiazolidinediones Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antidiabetic Thiazolidinediones Revenue Market Share by Region (2020-2025)
 Table 23. Global Antidiabetic Thiazolidinediones Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antidiabetic Thiazolidinediones Revenue Market Share by Region (2026-2031)
 Table 25. North America Antidiabetic Thiazolidinediones Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antidiabetic Thiazolidinediones Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Antidiabetic Thiazolidinediones Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Antidiabetic Thiazolidinediones Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antidiabetic Thiazolidinediones Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antidiabetic Thiazolidinediones Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antidiabetic Thiazolidinediones Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Antidiabetic Thiazolidinediones Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Antidiabetic Thiazolidinediones Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antidiabetic Thiazolidinediones Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antidiabetic Thiazolidinediones Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Antidiabetic Thiazolidinediones Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antidiabetic Thiazolidinediones Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antidiabetic Thiazolidinediones Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antidiabetic Thiazolidinediones Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Antidiabetic Thiazolidinediones Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Antidiabetic Thiazolidinediones Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antidiabetic Thiazolidinediones Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Antidiabetic Thiazolidinediones Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antidiabetic Thiazolidinediones Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Antidiabetic Thiazolidinediones Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Antidiabetic Thiazolidinediones Sales Market Share by Type (2020-2025)
 Table 53. Global Antidiabetic Thiazolidinediones Sales Market Share by Type (2026-2031)
 Table 54. Global Antidiabetic Thiazolidinediones Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antidiabetic Thiazolidinediones Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antidiabetic Thiazolidinediones Revenue Market Share by Type (2020-2025)
 Table 57. Global Antidiabetic Thiazolidinediones Revenue Market Share by Type (2026-2031)
 Table 58. Global Antidiabetic Thiazolidinediones Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Antidiabetic Thiazolidinediones Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Antidiabetic Thiazolidinediones Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Antidiabetic Thiazolidinediones Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Antidiabetic Thiazolidinediones Sales Market Share by Application (2020-2025)
 Table 63. Global Antidiabetic Thiazolidinediones Sales Market Share by Application (2026-2031)
 Table 64. Global Antidiabetic Thiazolidinediones Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antidiabetic Thiazolidinediones Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antidiabetic Thiazolidinediones Revenue Market Share by Application (2020-2025)
 Table 67. Global Antidiabetic Thiazolidinediones Revenue Market Share by Application (2026-2031)
 Table 68. Global Antidiabetic Thiazolidinediones Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Antidiabetic Thiazolidinediones Price (USD/Pcs) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Sanofi Antidiabetic Thiazolidinediones Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Takeda Pharmaceuticals Company Information
 Table 76. Takeda Pharmaceuticals Description and Business Overview
 Table 77. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product
 Table 79. Takeda Pharmaceuticals Recent Developments/Updates
 Table 80. Eli Lilly Company Information
 Table 81. Eli Lilly Description and Business Overview
 Table 82. Eli Lilly Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Eli Lilly Antidiabetic Thiazolidinediones Product
 Table 84. Eli Lilly Recent Developments/Updates
 Table 85. Merck & Co. Company Information
 Table 86. Merck & Co. Description and Business Overview
 Table 87. Merck & Co. Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Merck & Co. Antidiabetic Thiazolidinediones Product
 Table 89. Merck & Co. Recent Developments/Updates
 Table 90. Novo Nordisk Company Information
 Table 91. Novo Nordisk Description and Business Overview
 Table 92. Novo Nordisk Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Novo Nordisk Antidiabetic Thiazolidinediones Product
 Table 94. Novo Nordisk Recent Developments/Updates
 Table 95. Bristol-Myers Squibb Company Information
 Table 96. Bristol-Myers Squibb Description and Business Overview
 Table 97. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product
 Table 99. Bristol-Myers Squibb Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Pfizer Antidiabetic Thiazolidinediones Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. AstraZeneca Company Information
 Table 106. AstraZeneca Description and Business Overview
 Table 107. AstraZeneca Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. AstraZeneca Antidiabetic Thiazolidinediones Product
 Table 109. AstraZeneca Recent Developments/Updates
 Table 110. GlaxoSmithKline Company Information
 Table 111. GlaxoSmithKline Description and Business Overview
 Table 112. GlaxoSmithKline Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. GlaxoSmithKline Antidiabetic Thiazolidinediones Product
 Table 114. GlaxoSmithKline Recent Developments/Updates
 Table 115. Boehringer Ingelheim Company Information
 Table 116. Boehringer Ingelheim Description and Business Overview
 Table 117. Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Boehringer Ingelheim Antidiabetic Thiazolidinediones Product
 Table 119. Boehringer Ingelheim Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Antidiabetic Thiazolidinediones Distributors List
 Table 123. Antidiabetic Thiazolidinediones Customers List
 Table 124. Antidiabetic Thiazolidinediones Market Trends
 Table 125. Antidiabetic Thiazolidinediones Market Drivers
 Table 126. Antidiabetic Thiazolidinediones Market Challenges
 Table 127. Antidiabetic Thiazolidinediones Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antidiabetic Thiazolidinediones
 Figure 2. Global Antidiabetic Thiazolidinediones Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antidiabetic Thiazolidinediones Market Share by Type: 2024 & 2031
 Figure 4. Rosiglitazone Product Picture
 Figure 5. Pioglitazone Product Picture
 Figure 6. Global Antidiabetic Thiazolidinediones Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Antidiabetic Thiazolidinediones Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Other
 Figure 11. Global Antidiabetic Thiazolidinediones Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Antidiabetic Thiazolidinediones Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Antidiabetic Thiazolidinediones Sales (2020-2031) & (K Pcs)
 Figure 14. Global Antidiabetic Thiazolidinediones Average Price (USD/Pcs) & (2020-2031)
 Figure 15. Antidiabetic Thiazolidinediones Report Years Considered
 Figure 16. Antidiabetic Thiazolidinediones Sales Share by Manufacturers in 2024
 Figure 17. Global Antidiabetic Thiazolidinediones Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Antidiabetic Thiazolidinediones Players: Market Share by Revenue in Antidiabetic Thiazolidinediones in 2024
 Figure 19. Antidiabetic Thiazolidinediones Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Antidiabetic Thiazolidinediones Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Antidiabetic Thiazolidinediones Sales Market Share by Country (2020-2031)
 Figure 22. North America Antidiabetic Thiazolidinediones Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Antidiabetic Thiazolidinediones Sales Market Share by Country (2020-2031)
 Figure 26. Europe Antidiabetic Thiazolidinediones Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Antidiabetic Thiazolidinediones Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Antidiabetic Thiazolidinediones Revenue Market Share by Region (2020-2031)
 Figure 34. China Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Antidiabetic Thiazolidinediones Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Antidiabetic Thiazolidinediones Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Antidiabetic Thiazolidinediones Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Antidiabetic Thiazolidinediones Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Antidiabetic Thiazolidinediones by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Antidiabetic Thiazolidinediones by Type (2020-2031)
 Figure 55. Global Antidiabetic Thiazolidinediones Price (USD/Pcs) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Antidiabetic Thiazolidinediones by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Antidiabetic Thiazolidinediones by Application (2020-2031)
 Figure 58. Global Antidiabetic Thiazolidinediones Price (USD/Pcs) by Application (2020-2031)
 Figure 59. Antidiabetic Thiazolidinediones Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Antidiabetic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidiabetic Combination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidiabetic Sulphonylureas Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Glycemic Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Combination Anti Diabetes Drugs Market Research Report 2025
Antidiabetic Biguanides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetic Therapeutic Drugs Market Research Report 2025
Diabetes Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Type 2 Diabetes Therapeutics Market Research Report 2025
Non Insulin Therapies for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetic Retinopathy Fundus Image assisted Diagnosis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Incretin Based Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Hypoglycemic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Insulin Hypoglycemic Drug Market Research Report 2025
Drugs to Treat Hypertriglyceridemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lipid lowering Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chlorzoxazone API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions